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1 Introduction 
 
The MET proto-oncogene, encoding the Hepatocyte Growth Factor receptor, is the 
prototype of a gene family encoding structurally homologous heterodimeric tyrosine 
kinase receptors, including human RON (19) and avian SEA (8). It can be converted 
into an oncogene by rearrangement of the kinase domain with a N-terminal unrelated 
sequence designated TPR (3). The kinase activity of the encoded hybrid protein (Tpr-
Met) is deregulated, since two leucine-zipper motifs present in the Tpr moiety promote 
its constitutive dimerization (18). This conformation mimics receptor activation 
following ligand binding. 
 The product of RON has been identified as the receptor for MSP (Macrophage 
Stimulating Protein; 6, 24). MSP actually exerts a wide spectrum of biological 
activities, mainly on epithelial, neuro-endocrine and hemopoietic cells (7, 9). 
Furthermore, naturally-occurring transforming counterparts of RON have not been 
identified. On the contrary, both the human homologue of avian Sea and its ligand are 
still elusive. The oncogenic form of SEA (Sarcoma, Erythroblastosis, Anaemia) has 
been identified as the transforming component of the Avian Erythroblastosis S13 
retrovirus, by fusion of  extracellular and transmembrane regions of the viral envelope 
protein with the SEA tyrosine kinase (21). 
 It has been demonstrated that ligand-stimulation of Met, Ron and Sea induces cell 
growth, “scattering”, and tubulogenesis (13). These pleiotropic effects are elicited by 
receptor activation and phosphorylation of two critical carboxy-terminal tyrosine 
residues embedded in the sequence, which acts as docking site for multiple SH2-
containing cytoplasmic effectors. The multifunctional docking site responsible for Met 
signalling is conserved in the evolutionary related receptors (9, 16). 
 
 
2 Results and Discussion 
 
2.1 Constitutive activation of Met, Ron and Sea tyrosine kinases 
We used a recombinant approach to obtain constitutively active Ron and Sea tyrosine 
kinase designed according to the structure of Tpr-Met (Fig.1A). Tpr-Ron and Tpr-Sea 
cDNAs were stable expressed in NIH 3T3 fibroblasts. Level of expression and 
tyrosine phosphorylation of the recombinant chimaeras were analysed in stable 
transfectants by immunoprecipitation and Western blotting. Their enzymatic activity 
was examined by in vitro autokinase assays. All chimaeras were found to be expressed 
at comparable levels and highly phosphorylated on tyrosine both in vivo and in vitro 
(Table I).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. (A) Schematic representation of the chimaeric proteins containing Tpr and the 
intracellular domains of Met, Ron and Sea. The leucine zipper motifs (LZipA and LZipB) and 
the receptor intracellular subdomains are indicated at the top. (B) Schematic representations of 
the "swapped" chimaeras in which the tyrosine kinase subdomains are exchanged between Tpr-
Met and Tpr-Ron. Acronyms on the right identifies the different constructs. 
 
2.2  Transformation is linked to the functional features of the kinase domains 
Given the strong correlation between the transforming ability and the tyrosine kinase 
activity of the MET oncogene product (3), we assayed the transforming ability of the 
constitutively activated Met, Ron and Sea kinases. Tpr-Met, Tpr-Ron and Tpr-Sea 
were tested in a focus forming assay following  transfection in NIH3T3 fibroblasts. 
Cells transfected with Tpr-Sea yielded a two fold higher frequency of foci compared 
with Tpr-Met. The reason of this behaviour can be explained by the presence of a 
duplicated Grb-2 binding site in its C-terminal multifunctional docking site 
(Y1360VNL-X3 -Y
1367VNL). According to this hypothesis, it has been demonstrated 
that duplication of the Grb-2 binding site in Tpr-Met causes signalling reinforcement 
along the Ras pathway, and enhances transformation (17). Unexpectedly, Tpr-Ron 
was completely unable to induce foci of transformation (Table I). 
 To understand the differences observed in cell transformation we "swapped" the 
Ron tyrosine kinase subdomain with the corresponding Met region (Fig. 1B). The 
recombinant proteins were all expressed with the same efficiency, equally capable of 
autophosphorylation on tyrosine in vivo, and displayed comparable kinase activities in 
vitro. The transforming potential of "swapped" Tpr-chimaeras was analysed in focus 
forming assays and compared with that of Tpr-Met and Tpr-Ron. All Tpr-chimaeras 
bearing the Ron kinase domain (Tpr-Ron and Tpr-Met.KR) did not induce foci of 
transformation. Conversely, the chimaeras containing the Met kinase (Tpr-Met and 
Tpr-Ron.KM) were transforming.  
 We ruled out that Tpr-Ron signalling involved specific effectors different from 
those recruited by Tpr-Met, on the basis of the experiments performed with the C-
terminal "swapped" chimaeras. Surprisingly, the Ron C-terminal tail was found to be 
even better than the Met tail in inducing cell transformation. The Ron tail includes the 
conserved multifunctional docking site (Y1353VQL-X3-Y
1360MNL) that in vitro and in 
vivo binds the same set of SH2-containing signal transducers bound by Met 
(Y1349VHV-X3-Y
1356VNV; 16). Actually, the Ron tail can recruit  the Grb-2/Sos 
complex through Y1360MNL (9). 
 Altogether these experiments show that the transforming ability of Tpr-Ron and 
Tpr-Met is linked to their kinase domains. 
 
2.3  Catalytic efficiency of Met and Ron kinases  
There are several reports showing that the oncogenic potential of a tyrosine kinase is 
dramatically influenced by differences in the catalytic efficiency; as in the case of the 
EGF receptor (15), of pp60c-src (10) and the proto-oncogene Neu (11). To evaluate the 
catalytic efficiency of Tpr-Met and Tpr-Ron we determined the kinetic parameters for 
tyrosine autophosphorylation and for the exogenous substrate MBP (Myelin Basic 
Protein) phosphorylation. 
    The apparent Michaelis-Menten constant [KM (app)] of Tpr-Met and Tpr-Ron for 
MBP was in the same order of magnitude (1.76 ± 0.5 µM and 1.79 ± 0.3 µM, 
respectively). On the contrary, there is a strong difference in Vmax between Met and 
Ron kinases (1.15 ± 0.07 µM and 0.24 ± 0.01 µM, respectively ). 
 The reported data show that the catalytic efficiency of Tpr-Ron - expressed as a 
ratio between the Vmax  and the KM (MBP) -  is five times lower than the Vmax of Tpr-
Met (0.13 vs. 0.65 pmol/min, respectively). This suggests that catalytic efficiency is 
the parameter that discriminates the oncogenic potential of the two kinases. 
 
2.4  Invasive phenotype evoked by the Tpr-chimaeras 
We next investigated cell motility, and invasiveness. NIH3T3 fibroblasts expressing 
Tpr-Ron - despite the low efficiency of its kinase - migrated through polycarbonate 
filters and displayed invasive migration through the artificial basement membrane. 
Cell migration and matrix invasion induced by Tpr-Ron were comparable to those 
induced by transfection of Tpr-Met (Table I). Tpr-Ron, in spite of its weak kinase, 
fulfils the requirements for activating cell migration and matrix invasion, and provides 
a naturally occurring example of dissociation between the two arms of the biological 
response triggered by the Met family of receptors. 
 In contrast with the above, cells expressing Tpr-Sea, that displays an higher 
transforming ability than Tpr-Met, did not elicit a fully invasive phenotype and 
displayed only a modest increase in cell motility as well as in matrix invasion. Tpr-Sea 
docking site has two identical Y*VNL sequences, both binding Grb-2 at high affinity 
(22). This may prevent recruitment of the necessary amount of PI 3-Kinase for 
promoting motility and invasion, as demonstrated by a Tpr-Met mutant which binds 
two Grb-2 molecules but is lacking for binding to PI 3-Kinase. This mutant 
transformed host cells with higher efficiency, but was unable to trigger matrix 
invasion and metastasis, indicating that concomitant activation of the two pathways is 
necessary for the fully malignant phenotype (Giordano et al., 1996, submitted for 
publication).  
 
2.5 Cell polarisation induced by Tpr-Chimaeras  
MDCK epithelial cell line is a sensitive target for signals controlling polarised growth. 
These cells, when seeded in 3D collagen gels and stimulated with HGF, migrate, 
proliferate, and polarise into collagen matrices. This complex regulation results in the 
formation of branched tubular structures (14). MDCK cells expressing recombinant 
Tpr-Ron formed cysts developing few spikes that evolved into long and unbranching 
tubules. On the other hand, uncontrolled activation of Tpr-Met in these epithelial cells 
boosts cell proliferation, as shown by the formation of larger spherical cysts, but fails 
to activate the differentiative program. Also the clones expressing recombinant Tpr-
Sea grew as larger spherical cysts, which never formed tubular structures (Table I). 
Tpr-Ron appears to be able to drive part of the morphogenetic program, inducing 
linear tubulogenesis but not branching, as occurred in the case of HGF stimulation in 
presence of TGF-β and vitronectin (20). This suggests that number and morphology of 
the tubule structures are influenced by the combination of both tyrosine kinase 
signalling and ECM receptors (2).  
 The Tpr-Ron.KM chimaera did not induce tubules in MDCK cells, but formed large 
cysts as well, whereas the counterpart construct, Tpr-Met.KR, led to unbranching 
morphogenesis as did Tpr-Ron. A potential explanation for the behaviour of the Met 
kinase-based constructs could be that the high level of signalling conveyed by the Met 
kinase, optimal to induce unrestrained proliferation, interferes with the 
accomplishment of the morphogenic program. On the other hand, the low signalling 
threshold attained by the Ron kinase seems permissive and adequate to activate at least 
part of the morphogenic program. This can be explained by differential activation of 
critical genes due to a lower dosage of transcriptional activators induced by Ron (1). 
 These data demonstrate that constitutive activation of Ron and Met kinases 
differentially induces the morphogenic program, independently from the nature of the 
transducing multifunctional docking site. 
 
Table I: Biochemical and biological characterisation of the Tpr-chimaeras. 
 
Chimaera 
Kinase 
activity* 
Density 
arrested growth
Transforming 
ability 
Migration and 
invasion 
Cell 
polarisation  
Tpr-Met ++ - + + - 
Tpr-Ron ++ + - + + 
Tpr-Sea ++ - ++ +/- - 
Tpr-Met.KR ++ n.d. - + + 
Tpr-Ron.KM ++ n.d. ++ ++ - 
* Measured by in vivo tyrosine phosphorylation and in vitro autophosphorylation  
 
2.6 MAP kinase activation by Tpr-Met, Tpr-Ron and Tpr-Sea 
Cell transformation requires a strong mitogenic signal for which MAP kinase 
phosphorylation is a mandatory step (4). MAP kinase activation in pooled stable NIH 
3T3 transfectants was analysed by phosphorylation of MBP exogenous substrate after 
specific immunoprecipitation. In cells expressing Tpr-Sea and Tpr-Met, the MAP 
kinase was activated seven and six fold over the background respectively,  while 
expression of Tpr-Ron resulted only in a modest increase of MAP kinase activity (Fig. 
2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. MAP kinase activation by Tpr-Sea, Tpr-Ron and Tpr-Met. The assay was performed by 
measuring the amount of 32P transferred to myelin basic protein (MBP) by MAP kinase 
immunoprecipitated with anti-p42ERK2 antibodies. MAP kinase activation is expressed as fold 
increase over the background, in triplicate determinations (bars = S.D.). 
 
MAP kinase stimulation, however, was significant and correlated with induction of 
cell proliferation. Cells expressing Tpr-Met or Tpr-Sea acquired a transformed 
behaviour characterised by unrestrained proliferation. Cells expressing Tpr-Ron were 
able to grow in low serum, but their growth was arrested when saturation density was 
reached (contact-arrested condition)(Table I).  
 Then we conclude that the Ron-dependent activation of the MAP kinase pathway 
does not lead to cell transformation, as occurs in the case of Tpr-Met and Tpr-Sea. A 
possible explanation is that Met and Sea kinases activate the MAP kinase pathway 
above a given threshold, that is not reached by the weak intensity of the Ron kinase 
signal, due to the relative low catalytic efficiency of its kinase. It has been 
demonstrated that a quantitative difference in MAP kinase activation is translated into 
a qualitative difference in transcription factors activation, leading to specific gene 
expression (12). The proliferative vs differentiative/morphogenetic responses are 
modulated by the intensity and duration of the MAP kinase activation, that results in 
the phosphorylation of transcription factors at various levels (5, 23). According to this 
interpretation, the higher threshold of MAP kinase activity induced by Tpr-Met and 
Tpr-Sea causes a higher nuclear concentration of transcription factors that can induce 
the expression of specific genes associated to cell transformation. On the contrary, the 
lower threshold of MAP kinase activity attained by Tpr-Ron signalling maintains a 
lower nuclear level of transcriptional activators, leading to expression of other critical 
different genes, associated to cell invasiveness and morphogenesis but not to cell 
transformation. 
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